Pallas Capital Advisors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-12,914
Closed -$1.14M – 262
2023
Q1
$1.14M Buy
12,914
+9
+0.1% +$847 0.11% 138
2022
Q4
$1.28M Sell
12,905
-9,130
-41% -$1.05M 0.13% 121
2022
Q3
$2.73M Buy
22,035
+580
+3% +$63.6K 0.3% 80
2022
Q2
$2.37M Sell
21,455
-1,460
-6% -$145K 0.33% 64
2022
Q1
$2.38M Buy
22,915
+2,210
+11% +$229K 0.3% 69
2021
Q4
$1.93M Buy
20,705
+1,109
+6% +$123K 0.24% 77
2021
Q3
$2.09M Buy
19,596
+2,883
+17% +$306K 0.23% 84
2021
Q2
$1.69M Buy
16,713
+1,462
+10% +$127K 0.24% 80
2021
Q1
$1.4M Buy
+15,251
New +$1.13M 0.31% 60

Other funds holding AMN

Pallas Capital Advisors's AMN Position: Q2 2023 in Review

Pallas Capital Advisors sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 12,914 shares — an estimated $1.14M sold.

Pallas Capital Advisors first reported a position in AMN in Q1 2021 and held it in 9 quarters. The position peaked at $2.73M in Q3 2022. 425 funds tracked by Wall St. Rank hold AMN as of Q2 2023.

  • Pallas Capital Advisors reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
  • Pallas Capital Advisors sold 12,914 AMN Healthcare shares in Q2 2023, an estimated $1.14M.
  • Pallas Capital Advisors first reported a position in AMN Healthcare in Q1 2021 and held it in 9 quarters.
  • Pallas Capital Advisors's AMN Healthcare position peaked at $2.73M in Q3 2022.
  • 425 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.

Based on Pallas Capital Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.